NDC 50102-300

Lyleq

Norethindrone

Lyleq is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Afaxys Pharma, Llc. The primary component is Norethindrone.

Product ID50102-300_3e4fe08d-3819-4e76-8611-b98d5226b741
NDC50102-300
Product TypeHuman Prescription Drug
Proprietary NameLyleq
Generic NameNorethindrone
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2016-09-23
Marketing CategoryANDA / ANDA
Application NumberANDA207304
Labeler NameAfaxys Pharma, LLC
Substance NameNORETHINDRONE
Active Ingredient Strength0 mg/1
Pharm ClassesProgesterone Congeners [CS],Progestin [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50102-300-13

3 PACKAGE in 1 CARTON (50102-300-13) > 1 BLISTER PACK in 1 PACKAGE (50102-300-11) > 28 TABLET in 1 BLISTER PACK (50102-300-01)
Marketing Start Date2016-09-23
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Lyleq" or generic name "Norethindrone"

NDCBrand NameGeneric Name
50102-300LyleqNORETHINDRONE
53002-1793LyleqNORETHINDRONE
51862-102CamilaNorethindrone
51862-884CAMILANORETHINDRONE
16714-440DEBLITANENorethindrone
0555-0344ErrinNorethindrone
51862-100ErrinNorethindrone
51862-886ERRINNORETHINDRONE
57297-877Jencyclanorethindrone
52544-892JolivetteNORETHINDRONE
50102-100LYZAnorethindrone
53002-1687LYZAnorethindrone
52544-629Nora BENorethindrone
0378-7272NorethindroneNorethindrone
0378-7292NORETHINDRONEnorethindrone
50090-2150NorethindroneNorethindrone
50090-6161NORETHINDRONENORETHINDRONE
57297-876NORETHINDRONENORETHINDRONE
63187-748NorethindroneNorethindrone
42291-650Norethindrone AcetateNorethindrone
50268-602Norethindrone AcetateNorethindrone
50090-3235Norlydanorethindrone
51660-127NORLYROCnorethindrone
50458-194Ortho MicronorNORETHINDRONE
16714-441SHAROBELNorethindrone
50102-200TulanaNORETHINDRONE
53002-2687TulanaNORETHINDRONE

Trademark Results [Lyleq]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LYLEQ
LYLEQ
88675906 not registered Live/Pending
Afaxys, Inc.
2019-10-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.